Lipid-Lowering Efficacy and Safety of a New Generic Rosuvastatin in Koreans: an 8-Week Randomized Comparative Study with a Proprietary Rosuvastatin
- DOI
- 10.12997/jla.2020.9.2.283
- Published
- 2020
- Container
- Journal of Lipid and Atherosclerosis
- Publisher
- XMLink
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.12997/jla.2020.9.2.283,
title = {Lipid-Lowering Efficacy and Safety of a New Generic Rosuvastatin in Koreans: an 8-Week Randomized Comparative Study with a Proprietary Rosuvastatin},
author = {Hyoeun Kim and Chan Joo Lee and Donghoon Choi and Byeong-Keuk Kim and In-Cheol Kim and Jung-Sun Kim and Chul-Min Ahn and Geu-Ru Hong and In-Jeong Cho and Chi-Young Shim and Sang-Hak Lee},
year = {2020},
journal = {Journal of Lipid and Atherosclerosis},
doi = {10.12997/jla.2020.9.2.283},
url = {https://doi.org/10.12997/jla.2020.9.2.283}
}RIS
TY - JOUR TI - Lipid-Lowering Efficacy and Safety of a New Generic Rosuvastatin in Koreans: an 8-Week Randomized Comparative Study with a Proprietary Rosuvastatin AU - Hyoeun Kim AU - Chan Joo Lee AU - Donghoon Choi AU - Byeong-Keuk Kim AU - In-Cheol Kim AU - Jung-Sun Kim AU - Chul-Min Ahn AU - Geu-Ru Hong AU - In-Jeong Cho AU - Chi-Young Shim AU - Sang-Hak Lee PY - 2020 JO - Journal of Lipid and Atherosclerosis DO - 10.12997/jla.2020.9.2.283 UR - https://doi.org/10.12997/jla.2020.9.2.283 ER -
APA
Kim, H., Lee, C. J., Choi, D., Kim, B., Kim, I., Kim, J., Ahn, C., Hong, G., Cho, I., Shim, C., & Lee, S. (2020). Lipid-Lowering Efficacy and Safety of a New Generic Rosuvastatin in Koreans: an 8-Week Randomized Comparative Study with a Proprietary Rosuvastatin. Journal of Lipid and Atherosclerosis. https://doi.org/10.12997/jla.2020.9.2.283
Source records
- crossref · retrieved 2026-09-26T23:27:02.300Z